Kirkland Advises Bain Capital on Investment in Greenphire and Suvoda

Kirkland & Ellis is advising Bain Capital Tech Opportunities on a significant minority investment in the combination of Greenphire, a leader in clinical trial payments, financial management and patient support tools, and Suvoda, a global clinical trial technology company specializing in randomization and trial supply management, consent, and patient outcomes data collection solutions for complex, life-sustaining studies. Bain Capital is investing alongside software investment firm Thoma Bravo, which is serving as the lead strategic investor. The combination will create a powerful end-to-end platform to support the patient journey in clinical trials and help bring medicines to those who need them most. The transaction was announced on January 13, 2025. Financial details were not disclosed.

Read the transaction press release

The Kirkland team includes corporate lawyers Ziyad Ziyadzade, Jack Silverman, Chris Elder and Matthew O’Brien; capital markets lawyers Josh Korff and Alborz Tolou; and tax lawyers Mike Carew and Christine Lehman.